Clear Harbor Asset Management LLC Invests $320,000 in HCA Healthcare, Inc. (NYSE:HCA)

Clear Harbor Asset Management LLC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, Holdings Channel.com reports. The fund purchased 1,065 shares of the company’s stock, valued at approximately $320,000.

Other institutional investors have also recently made changes to their positions in the company. Clarius Group LLC increased its position in shares of HCA Healthcare by 19.1% during the fourth quarter. Clarius Group LLC now owns 1,540 shares of the company’s stock worth $462,000 after acquiring an additional 247 shares during the period. Arkadios Wealth Advisors boosted its stake in shares of HCA Healthcare by 46.9% in the 4th quarter. Arkadios Wealth Advisors now owns 3,435 shares of the company’s stock valued at $1,031,000 after buying an additional 1,096 shares during the period. Canoe Financial LP increased its stake in shares of HCA Healthcare by 226,952.9% during the fourth quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock worth $69,513,000 after buying an additional 231,492 shares during the period. Merit Financial Group LLC grew its holdings in HCA Healthcare by 137.7% during the 4th quarter. Merit Financial Group LLC now owns 1,569 shares of the company’s stock worth $471,000 after acquiring an additional 909 shares in the last quarter. Finally, Wedge Capital Management L L P NC lifted its position in shares of HCA Healthcare by 7.7% during the 4th quarter. Wedge Capital Management L L P NC now owns 116,075 shares of the company’s stock worth $34,840,000 after purchasing an additional 8,329 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Up 0.3 %

HCA Healthcare stock opened at $319.53 on Thursday. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare, Inc. has a 1-year low of $278.68 and a 1-year high of $417.14. The stock’s 50 day moving average price is $315.10 and its 200 day moving average price is $353.07. The company has a market cap of $80.94 billion, a PE ratio of 14.35, a price-to-earnings-growth ratio of 1.06 and a beta of 1.64.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were given a dividend of $0.66 per share. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.83%. HCA Healthcare’s payout ratio is 11.85%.

Wall Street Analyst Weigh In

HCA has been the subject of a number of recent analyst reports. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Barclays cut their price objective on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a report on Friday, November 8th. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Finally, KeyCorp decreased their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $385.27.

Insider Activity at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.